.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Checkpoint Inhibitors in Head and Neck Cancer

EP. 1: Checkpoint Inhibitors in HNSCC

July 7th 2017

EP. 2: Checkpoint Inhibitors for Recurrent HNSCC

July 7th 2017

EP. 3: Pembrolizumab in HNSCC

July 7th 2017

EP. 4: Nivolumab in HNSCC

July 7th 2017

EP. 5: Patient Selection in Treating HNSCC

July 7th 2017

EP. 6: Predictive Biomarkers in HNSCC

July 7th 2017

EP. 7: Emerging Agents to Treat HNSCC

July 7th 2017

EP. 8: Future Directions in Treating HNSCC

July 7th 2017